sorafenib has been researched along with terbinafine in 2 studies
| Studies (sorafenib) | Trials (sorafenib) | Recent Studies (post-2010) (sorafenib) | Studies (terbinafine) | Trials (terbinafine) | Recent Studies (post-2010) (terbinafine) |
|---|---|---|---|---|---|
| 6,520 | 730 | 5,251 | 2,164 | 280 | 809 |
| Protein | Taxonomy | sorafenib (IC50) | terbinafine (IC50) |
|---|---|---|---|
| cystic fibrosis transmembrane conductance regulator | Homo sapiens (human) | 25 | |
| Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 4.1295 | |
| Alpha-2A adrenergic receptor | Homo sapiens (human) | 5.7029 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.2 | |
| Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 4.1295 | |
| Squalene monooxygenase | Homo sapiens (human) | 6 | |
| Sigma non-opioid intracellular receptor 1 | Homo sapiens (human) | 0.5602 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Cao, R; Chamberlain, P; Cheah, JH; Collins, J; Esfandiary, T; Gardner, A; Hayward, AM; Hess, K; Ishida, K; Kirtane, AR; L'Heureux, J; Langer, R; Leboeuf, D; Lopes, A; Lytton-Jean, A; Navamajiti, N; Reker, D; Rogner, J; Rybakova, Y; Smekalova, EM; Soule, CK; Tamang, SM; Traverso, G; von Erlach, T; Yang, JW; Yun, D; Zhang, RM | 1 |
1 review(s) available for sorafenib and terbinafine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 other study(ies) available for sorafenib and terbinafine
| Article | Year |
|---|---|
Computationally guided high-throughput design of self-assembling drug nanoparticles.
Topics: Animals; Candida albicans; Computer Simulation; Drug Carriers; Drug Design; Drug Evaluation, Preclinical; Dynamic Light Scattering; Excipients; Female; Glycyrrhizic Acid; High-Throughput Screening Assays; Humans; Machine Learning; Mice, Inbred Strains; Nanoparticles; Skin Absorption; Sorafenib; Taurocholic Acid; Terbinafine; Tissue Distribution; Xenograft Model Antitumor Assays | 2021 |